Detection of Pneumocystis carinii DNA in blood specimens from human immunodeficiency virus-infected patients by nested PCR. 1999

M Rabodonirina, and L Cotte, and A Boibieux, and K Kaiser, and M Mayencon, and D Raffenot, and C Trepo, and D Peyramond, and S Picot
Departement de Parasitologie et de Mycologie, Universite Claude-Bernard, Lyon, France. rabodoni@rockefeller.univ-lyon1.fr

The detection of Pneumocystis carinii DNA in blood by PCR could be useful for studying the natural history of pneumocystosis and could also be a noninvasive diagnostic method. The results of previous studies are nevertheless conflicting. In our study, we compared three commercially available DNA extraction kits (GeneReleaser, QIAamp Tissue Kit, and ReadyAmp Genomic DNA Purification System) and proteinase K and proteinase K-phenol-chloroform treatments for the extraction of P. carinii DNA from dilutions of a P. carinii f. sp. hominis cyst suspension mixed with human whole blood. A rapid and simple nested PCR protocol which amplifies a portion of the mitochondrial large-subunit rRNA gene was applied to all the extraction products. The QIAmp Tissue Kit was the most effective kit for the isolation of amplification-ready P. carinii DNA and was used with nested PCR for the testing of whole-blood specimens from 35 immunocompetent control patients and 84 human immunodeficiency virus (HIV)-infected patients investigated for pulmonary disease and/or fever. In HIV-infected patients, P. carinii DNA was detected by nested PCR in blood samples from 3 of 14 patients with microscopically proven P. carinii pneumonia, 7 of 22 patients who were considered to be colonized with P. carinii, and 9 of 48 patients who were neither infected nor colonized with P. carinii. P. carinii DNA was not detected in blood specimens from the 35 immunocompetent patients. P. carinii DNA in blood might represent viable P. carinii organisms or DNA complexes released from pulmonary phagocytes. In conclusion, P. carinii DNA may be detected in whole blood from HIV-infected patients, but the nature and the meaning of the circulating form of P. carinii remain to be established.

UI MeSH Term Description Entries
D007121 Immunocompetence The ability of lymphoid cells to mount a humoral or cellular immune response when challenged by antigen. Competence, Immunologic,Immunologic Competence,Immunological Competence,Competence, Immunological
D008828 Microbiological Techniques Techniques used in microbiology. Microbiologic Technic,Microbiologic Technics,Microbiologic Technique,Microbiological Technics,Technic, Microbiologic,Technics, Microbiological,Technique, Microbiologic,Techniques, Microbiologic,Microbiologic Techniques,Microbiological Technic,Microbiological Technique,Technic, Microbiological,Technics, Microbiologic,Technique, Microbiological,Techniques, Microbiological
D011010 Pneumocystis A genus of ascomycetous FUNGI, family Pneumocystidaceae, order Pneumocystidales. It includes various host-specific species causing PNEUMOCYSTIS PNEUMONIA in humans and other MAMMALS. Pneumocysti
D011020 Pneumonia, Pneumocystis A pulmonary disease in humans occurring in immunodeficient or malnourished patients or infants, characterized by DYSPNEA, tachypnea, and HYPOXEMIA. Pneumocystis pneumonia is a frequently seen opportunistic infection in AIDS. It is caused by the fungus PNEUMOCYSTIS JIROVECII. The disease is also found in other MAMMALS where it is caused by related species of Pneumocystis. P carinii Pneumonia,P. carinii Pneumonia,P. jirovecii Pneumonia,PCP Pneumonia,Pneumocystis Pneumonia,Pneumocystosis,Pneumonia, Interstitial Plasma Cell,PCP Infection,Pneumocystis carinii Pneumonia,Pneumocystis jirovecii Pneumonia,Pneumonia, Pneumocystis carinii,Infection, PCP,P carinii Pneumonias,P. carinii Pneumonias,P. jirovecii Pneumonias,PCP Infections,PCP Pneumonias,Pneumocystis Pneumonias,Pneumocystoses,Pneumonia, P carinii,Pneumonia, P. carinii,Pneumonia, P. jirovecii,Pneumonia, PCP,Pneumonia, Pneumocystis jirovecii,Pneumonias, PCP
D004271 DNA, Fungal Deoxyribonucleic acid that makes up the genetic material of fungi. Fungal DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain
D017088 AIDS-Related Opportunistic Infections Opportunistic infections found in patients who test positive for human immunodeficiency virus (HIV). The most common include PNEUMOCYSTIS PNEUMONIA, Kaposi's sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with Mycobacterium avium complex, Microsporidium, and Cytomegalovirus. HIV-Related Opportunistic Infections,Opportunistic Infections, AIDS-Related,Opportunistic Infections, HIV-Related,AIDS Related Opportunistic Infections,AIDS-Related Opportunistic Infection,HIV Related Opportunistic Infections,HIV-Related Opportunistic Infection,Infection, HIV-Related Opportunistic,Infections, HIV-Related Opportunistic,Opportunistic Infection, AIDS-Related,Opportunistic Infection, HIV-Related,Opportunistic Infections, AIDS Related,Opportunistic Infections, HIV Related

Related Publications

M Rabodonirina, and L Cotte, and A Boibieux, and K Kaiser, and M Mayencon, and D Raffenot, and C Trepo, and D Peyramond, and S Picot
October 1997, Diagnostic microbiology and infectious disease,
M Rabodonirina, and L Cotte, and A Boibieux, and K Kaiser, and M Mayencon, and D Raffenot, and C Trepo, and D Peyramond, and S Picot
February 1990, Archives of internal medicine,
M Rabodonirina, and L Cotte, and A Boibieux, and K Kaiser, and M Mayencon, and D Raffenot, and C Trepo, and D Peyramond, and S Picot
March 2002, Medicina clinica,
M Rabodonirina, and L Cotte, and A Boibieux, and K Kaiser, and M Mayencon, and D Raffenot, and C Trepo, and D Peyramond, and S Picot
March 2000, Journal of clinical microbiology,
M Rabodonirina, and L Cotte, and A Boibieux, and K Kaiser, and M Mayencon, and D Raffenot, and C Trepo, and D Peyramond, and S Picot
September 2003, The Southeast Asian journal of tropical medicine and public health,
M Rabodonirina, and L Cotte, and A Boibieux, and K Kaiser, and M Mayencon, and D Raffenot, and C Trepo, and D Peyramond, and S Picot
January 1997, The Journal of eukaryotic microbiology,
M Rabodonirina, and L Cotte, and A Boibieux, and K Kaiser, and M Mayencon, and D Raffenot, and C Trepo, and D Peyramond, and S Picot
September 1995, Journal of clinical microbiology,
M Rabodonirina, and L Cotte, and A Boibieux, and K Kaiser, and M Mayencon, and D Raffenot, and C Trepo, and D Peyramond, and S Picot
May 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
M Rabodonirina, and L Cotte, and A Boibieux, and K Kaiser, and M Mayencon, and D Raffenot, and C Trepo, and D Peyramond, and S Picot
January 1999, The Journal of eukaryotic microbiology,
M Rabodonirina, and L Cotte, and A Boibieux, and K Kaiser, and M Mayencon, and D Raffenot, and C Trepo, and D Peyramond, and S Picot
November 1995, Journal of clinical microbiology,
Copied contents to your clipboard!